Status:
COMPLETED
The Role of Serum Anticholinergic Activity in ACVB Patients
Lead Sponsor:
Heidelberg University
Conditions:
Acetylcholine
Cognition
Eligibility:
All Genders
55-90 years
Brief Summary
Drugs with anticholinergic potential increase the risk of postoperative transient and persistent cognitive dysfunction especially in cardiac patients. The investigators main goal is to identify preope...
Eligibility Criteria
Inclusion
- written compliance to the study participation
- a good knowledge in German speech
- no red/ green blindness
- no previous neurological and/or psychiatric illness
- good ability to see and to hear
- Mini-Mental-State-Examination (MMSE) better than 25 points
Exclusion
- no written compliance to the study participation
- bad knowledge in German speech
- red/ green blindness
- previous neurological and/or psychiatric illness
- no ability to see and to hear
- Mini-Mental-State-Examination (MMSE) lower than 25 points
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00782938
Start Date
May 1 2008
End Date
January 1 2010
Last Update
January 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Heidelberg, Department of Anesthesiology, Heidelberg Medical School
Heidelberg, Baden-Wurttemberg, Germany, 69120